Susan M. Garthwaite

834 total citations
27 papers, 649 citations indexed

About

Susan M. Garthwaite is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Susan M. Garthwaite has authored 27 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Susan M. Garthwaite's work include Cardiac electrophysiology and arrhythmias (10 papers), Cardiac Arrhythmias and Treatments (8 papers) and Hormonal Regulation and Hypertension (5 papers). Susan M. Garthwaite is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Cardiac Arrhythmias and Treatments (8 papers) and Hormonal Regulation and Hypertension (5 papers). Susan M. Garthwaite collaborates with scholars based in United States, Japan and Canada. Susan M. Garthwaite's co-authors include Ellen G. McMahon, J. O. Holloszy, Bruce W. Craig, Suzanne Oparil, Elijah Saunders, J. Howard Pratt, Barbara Roniker, John M. Flack, Jay H. Kleiman and Yonghong Yang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and Journal of Applied Physiology.

In The Last Decade

Susan M. Garthwaite

25 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan M. Garthwaite United States 10 308 253 195 141 102 27 649
Michael Schwemmer Germany 13 166 0.5× 319 1.3× 211 1.1× 145 1.0× 40 0.4× 20 754
H. Steinberg United States 9 272 0.9× 215 0.8× 209 1.1× 162 1.1× 46 0.5× 10 670
G. Valsecchi Italy 10 172 0.6× 214 0.8× 302 1.5× 82 0.6× 42 0.4× 11 566
Kiyohide Nunoi Japan 14 244 0.8× 104 0.4× 146 0.7× 130 0.9× 20 0.2× 48 609
Sven Carlström Sweden 13 299 1.0× 133 0.5× 209 1.1× 170 1.2× 71 0.7× 31 640
James T. Hamlin United States 12 181 0.6× 199 0.8× 163 0.8× 122 0.9× 44 0.4× 19 685
Shinpei Morimoto Japan 13 207 0.7× 155 0.6× 53 0.3× 96 0.7× 25 0.2× 61 456
Lucrezia Di Marino Italy 13 282 0.9× 116 0.5× 215 1.1× 74 0.5× 37 0.4× 16 574
Jonas Millgård Sweden 15 114 0.4× 349 1.4× 152 0.8× 50 0.4× 20 0.2× 30 542
P Bonati Italy 4 438 1.4× 188 0.7× 198 1.0× 108 0.8× 17 0.2× 5 716

Countries citing papers authored by Susan M. Garthwaite

Since Specialization
Citations

This map shows the geographic impact of Susan M. Garthwaite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Garthwaite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Garthwaite more than expected).

Fields of papers citing papers by Susan M. Garthwaite

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan M. Garthwaite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Garthwaite. The network helps show where Susan M. Garthwaite may publish in the future.

Co-authorship network of co-authors of Susan M. Garthwaite

This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Garthwaite. A scholar is included among the top collaborators of Susan M. Garthwaite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Garthwaite. Susan M. Garthwaite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ketelslegers, Jean‐Marie, et al.. (2004). Biomarkers of prognosis in patients with post-acute-myocardial infarction heart failure: results of an EPHESUS sub-study. Digital Access to Libraries. 25. 582–582.
2.
Saruta, Takao, Shigeru Kageyama, Toshio Ogihara, et al.. (2004). Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Study. Journal of Clinical Hypertension. 6(4). 175–185. 40 indexed citations
3.
Garthwaite, Susan M. & Ellen G. McMahon. (2004). The evolution of aldosterone antagonists. Molecular and Cellular Endocrinology. 217(1-2). 27–31. 130 indexed citations
4.
Zannad, Faı̈ez, Jean‐Marie Ketelslegers, Ernesto L. Schiffrin, et al.. (2004). 1108-123 The effect of eplerenone on markers of cardiac fibrosis: Insights from EPHESUS. Journal of the American College of Cardiology. 43(5). A200–A200. 3 indexed citations
5.
Ketelslegers, Jean‐Marie, et al.. (2004). The effect of eplerenone on the cytokine osteopontin in post-MI heart failure: an EPHESUS substudy. Digital Access to Libraries. 25. 485–486. 2 indexed citations
6.
Flack, John M., Suzanne Oparil, J. Howard Pratt, et al.. (2003). Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. Journal of the American College of Cardiology. 41(7). 1148–1155. 183 indexed citations
7.
Ryan, Bernadette M., et al.. (2000). Two-Generation Oral (Diet) Reproductive Toxicity Study of Resorcinol Bis-Diphenylphosphate (Fyrolflex RDP) in Rats. International Journal of Toxicology. 19(4). 243–255. 4 indexed citations
8.
Garthwaite, Susan M., Keitaro Hashimoto, Aziz Karim, et al.. (1995). Bidisomide: An Investigational Antiarrhythmic Agent. Cardiovascular Drug Reviews. 13(1). 19–32. 2 indexed citations
9.
Gardiner, Peter, et al.. (1993). The Effect of Bidisomide (SC‐40230), a New Class Ia/Ib Antiarrhythmic Agent, on Defihrillation Energy Requirements in Dogs with Healed Myocardial Infarctions. Pacing and Clinical Electrophysiology. 16(2). 317–326. 3 indexed citations
10.
Garthwaite, Susan M., et al.. (1992). Electropharmacology of bidisomide in the normal intact canine heart. Drug Development Research. 27(4). 329–344. 4 indexed citations
11.
Garthwaite, Susan M., et al.. (1992). Rapid Infusions of Bidisomide or Disopyramide in Conscious Dogs. Journal of Cardiovascular Pharmacology. 20(2). 236–250. 3 indexed citations
12.
Desai, B.N., et al.. (1992). Bidisomide < Prop INN; USAN >. Drugs of the Future. 17(5). 374–374. 6 indexed citations
13.
Schneider, Paul, et al.. (1990). Simple in vitro method to characterize antiarrhythmic agents. Journal of Pharmacological Methods. 23(2). 107–116.
14.
Garthwaite, Susan M., et al.. (1989). Efficacy and Plasma Concentrations of SC-36602 in Canine Models of Ventricular Arrhythmia. Journal of Cardiovascular Pharmacology. 13(2). 218–226. 6 indexed citations
15.
Garthwaite, Susan M., et al.. (1989). Cardiovascular profile of a new anti-arrhythmic agent, SC-40230. Cardiovascular Research. 23(10). 897–903. 12 indexed citations
16.
Garthwaite, Susan M., et al.. (1989). Actisomide. Cardiovascular Drug Reviews. 7(1). 52–67. 4 indexed citations
17.
Desai, B.N., et al.. (1988). Synthesis and structure-activity relationships of a new series of antiarrhythmic agents: monobasic derivatives of disobutamide. Journal of Medicinal Chemistry. 31(11). 2158–2164. 8 indexed citations
18.
Garthwaite, Susan M., et al.. (1988). SC-36602, A New Antiarrhythmic Agent. Journal of Cardiovascular Pharmacology. 11(6). 657–666. 9 indexed citations
19.
Garthwaite, Susan M., et al.. (1986). Ageing, exercise and food restriction: effects on body composition. Mechanisms of Ageing and Development. 36(2). 187–196. 31 indexed citations
20.
Garthwaite, Susan M. & J. O. Holloszy. (1982). Increased permeability to sugar following muscle contraction. Inhibitors of protein synthesis prevent reversal of the increase in 3-methylglucose transport rate.. Journal of Biological Chemistry. 257(9). 5008–5012. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026